Object. Multicentric diffuse low-grade gliomas (DLGGs) are defined as widely separated lesions in different lobes or hemispheres where there is no anatomical continuity between lesions. This condition is rare and its clinicopathological characteristics have been scarcely described in the literature. Here, the authors report the first consecutive surgical series of multicentric DLGGs with functional and oncological outcomes.
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M ultiple gliomas-defined as the presence of 2 or more gliomas in an individual's CNS-are a well-recognized but relatively rare condition, accounting for 2%-9% of gliomas in patients. 2, 3, 9, 20, 31 They are often classified into 2 distinct entities: multifocal and multicentric gliomas. 3 Multifocal gliomas are defined as those lesions that result from dissemination or spread via established pathways, such as the commissural fibers and CSF, or local metastasis. In contrast, multicentric gliomas refer to widely separated lesions in different lobes or hemispheres whose distribution cannot be explained by any of the above-mentioned pathways or mechanisms. 3 To date, only a few series of multicentric gliomas have been described in the literature. 2, 3, 5, 9, 19, 25, 28, 31, 32, 40 In addition, most of those reported cases are associated with high-grade gliomas (Grade III and IV gliomas according to the WHO classification 21 ), 2, 3, 9, 19, 25, 31, 32 while descriptions of pure multicentric LGGs (WHO Grade I and II gliomas) are sparsely available. 2, 5, 28, 40 In this context, little is known regarding the clinicopathological features of multicentric DLGGs (that is, WHO Grade II gliomas) and consequently, appropriate management has not yet been optimized.
Here, we present clinical characteristics, surgical procedures, histopathological findings, and clinical outcomes of 5 consecutive cases of multicentric DLGGs. We also discuss the role of surgery in the management of this rare entity.
Methods

Selection of Patients
We performed a retrospective review of patients' medical records to identify those who were surgically treated for DLGGs between October 2000 and July 2012. Patients with multicentric DLGGs on the basis of criteria outlined by Batzdorf and Malamud 3 were included in this study. Clinical, surgical, and histopathological characteristics as well as clinical outcomes were collected and analyzed.
Surgical Procedure
Surgery was proposed with the aim of maximal resection of tumors and preservation of brain function. To achieve this goal, awake surgery with intraoperative functional brain mapping using cortical and subcortical electrical stimulation was performed. Technical details of our functional-guided surgical procedure have been described in previous reports.
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Extent of Resection and Clinical Outcomes
The extent of resection was determined on early postoperative FLAIR MRI obtained within 24 hours after surgery. Complete removal of the hyperintense area on postoperative FLAIR MRI was considered as GTR, whereas a residual volume of less than 10 ml on FLAIR imaging was defined as STR. All other cases were considered a partial resection. 4 Postoperatively, patients were observed regularly in the outpatient clinic at 3 months after surgery and every 6 months thereafter to evaluate neurological function and observe tumor behavior using MRI. The KPS score 18 was also evaluated at the time of follow-up.
Results
Clinicopathological features of the 5 patients are summarized in Table 1 .
Patient Population
Among 350 patients reviewed, 5 patients met the Batzdorf criteria and were included in this study. These 5 patients accounted for 1.4% of the surgically treated patients with DLGGs in our series. The patients consisted of 3 men and 2 women, whose mean age was 27.4 years (range 23-35 years). Four of the 5 patients were right-handed.
Seizure was noted as the initial clinical symptom in all patients except 1, in whom the discovery was made following imaging for headache symptoms.
Tumor Location
A total of 10 tumors were identified in our series of 5 patients (2 tumors per patient). The lesions were all synchronous and detected on initial neuroimaging. The tumors involved the same hemisphere in 4 patients (the right hemisphere in 1 patient and left hemisphere in 3 patients), and they involved both hemispheres in 1 patient. The most commonly affected regions were the frontal lobe and temporal lobe, followed by the parietal lobe. No DLGGs were identified within the occipital lobe, brainstem, or cerebellum in this series.
Surgical Outcome
A total of 9 operations were performed, including 1 partial tumor resection that had been performed at another hospital before our consultation (Case 3). In our first patient (Case 1, who underwent her first operation 138 months ago) we performed 2 surgeries: the first for a right temporal lesion, and the second 2 years later for a right frontal lesion. Because of a relapse 10 years after the first operation, a third surgery was performed under awake conditions at which time both tumors were resected (Fig. 1) . Similarly, a single surgery was performed in the more recent cases for multicentric tumors located in the same hemisphere (Cases 2-4, Figs. 2-4). For Case 5, a planned 2-stage surgery was performed (interoperative interval 52 days) because the tumors were located in opposite hemispheres (Fig. 5) .
For the total of 12 resections at our hospital, GTR was achieved in 6 surgeries and STR in the remaining 6 (there were no cases of partial resection). There was no death or severe permanent neurological deficit associated with any of the surgeries. Of note, a left upper quadrantanopia persisted after the first surgery for resection of the temporal lesion in Case 1; however, the patient's quality of life was not significantly affected and she was able to continue working.
The mean follow-up period after surgery was 46 months (range 11-138 months). At the most recent followup, seizures had been controlled with medications in 3 cases and without medications in 2 cases. All patients returned to their normal social and professional life and all had a KPS score of 90 or 100 at the most recent follow-up.
Histopathological and Molecular Examinations
Histopathological examination was performed on each lesion in all cases. Multicentric tumors were histopathologically identical in 4 cases: 3 patients had multicentric WHO Grade II oligodendrogliomas and 1 had a multicentric WHO Grade II astrocytoma. In contrast, the tumors in Case 5 had different histopathological features (a WHO Grade II oligodendroglioma and WHO Grade II astrocytoma).
All tumors were classified as WHO Grade II gliomas, although in Case 4 part of the pathological specimen exhibited a microfocus of anaplastic features. The Ki 67 labeling index varied between 1% and 15%.
In 4 patients both tumors had the same genetic profile (IDH1 mutation and no 1p19q codeletion). In 1 patient, although IDH1 mutation was found in both tumors, there was no 1p19q codeletion in the first glioma whereas there was a dissociation in the second glioma (that is, no 1p deletion and 19q deletion).
Adjuvant Therapy
Given that all tumors were pathologically confirmed DLGGs and resected either totally or subtotally, adjuvant therapy (chemotherapy and/or radiotherapy) was not administered routinely after surgery. However, in the patient in Case 1 the frontal lesion recurred 6 months after the resection despite GTR. Accordingly, temozolomide was administered for 18 months, which resulted in not only stabilization of the frontal tumor but also a partial reduction of the temporal residual tumor subtotally removed 2 years before. Nevertheless, both the frontal and temporal lesions evolved gradually on regular MRI after the withdrawal of the above-mentioned chemotherapy. Therefore, a third surgery was performed 10 years after the first operation to resect both lesions simultaneously (although the patient was still asymptomatic at the time of the third surgery). Part of the clinical course of the patient in Case 1 was reported previously. 40 In Case 3, temozolomide was initiated 25 months after surgery because the residual tumor in the temporal lobe gradually expanded over time although the frontal lesion was stable. In the other 3 cases, patients were simply followed after surgery and had not received adjuvant therapy as of the most recent follow-up.
Discussion
To the best of our knowledge, this is the first consecutive surgical series of multicentric DLGGs reported in the literature.
Incidence of Multicentric DLGGs
The incidence of multicentric DLGGs has not yet been well documented in the literature, but they are considered to be extremely rare entities. A previous autopsy study of 241 patients with gliomas revealed 18 cases of multicentric gliomas. Of these 18 cases, pure multicentric DLGGs consisting of solely low-grade lesions were found in only 1 case, indicating that the incidence was 0.41% among all glioma patients.
2 In our series, the incidence of multicentric DLGGs was 1.4% of our DLGG cases. This scarcity explains why few cases have been reported and why management of this entity has not been well established. Of note, multicentric DLGGs and gliomatosis are 2 distinct entities, resulting in different therapeutic strategies.
Clinicopathological Features
Age distribution, clinical manifestation, and tumor location in our series of multicentric DLGGs did not differ from those characteristics previously described in solitary DLGGs. 8, 30, 34 Interestingly, although the diagnosis was made because of seizures in 4 patients, the tumor was incidentally discovered in 1 patient (Case 1). However, during the follow-up of 138 months of this patient (who is still asymptomatic) tumor growth (and even regrowth after surgery) was observed. This suggests that the natural course of incidental multicentric DLGGs is the same as that of incidental unicentric DLGGs, which can demonstrate a constant progression of the tumor despite no neurological symptoms.
26
Regarding neuropathological features, although the histological characteristics were the same between the 2 tumors in 4 cases, different histopathological features were found in 1 patient (one tumor was an oligodendroglioma and the other tumor was an astrocytoma). In a relatively large series of 18 cases of multicentric gliomas, 6 cases had different histopathological appearances.
2 Neuropathological heterogeneity has also been described in several other case reports. 19, 25, 31 These previous findings along with our data highlight the uncertainty of a histopathological diagnosis determined from only a single lesion. Interestingly, molecular heterogeneity was also observed in 1 patient. This issue is important to adapt the optimal therapeutic management, which could be different for each tumor.
The Role of Extensive Resection in Multicentric DLGGs
Appropriate management of multicentric DLGGs is yet to be established. In solitary DLGGs mounting evidence suggests that extensive resection is significantly associated with a greater overall survival by delaying malignant transformation. 1, 4, 6, 7, 16, 23, 24, 27, 33, [35] [36] [37] 39, 41 Based on these previous studies, maximal resection while preserving brain function is considered the optimal treatment of DLGG.
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Accordingly, maximal resection may also be indicated for patients with multicentric DLGGs. Indeed, in our series no patient died and none experienced malignant transformation during a mean follow-up of 46 months after surgery. Moreover, reoperation can also be considered in recurrent multicentric DLGGs, as already recommended in recurrent solitary DLGGs. 22 As an example, in the patient in Case 1 of the present series, the patient has survived longer than 11 years and 3 surgeries and currently has stable disease. In addition, this case indicates that when the resection is not complete for functional reasons, chemotherapy may also be used before performing a subsequent resection, as already reported in unicentric DLGGs.
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Beyond oncological issues, it should be noted that all patients in the present series continue to enjoy their nor- mal life after surgery despite multiple tumors and multiple surgeries. First, this means that intraoperative mapping with functional-guided resection may allow preservation of the quality of life while maximizing the extent of resection in multicentric DLGGs (supported by the fact that there was no partial resection in this series), as previously demonstrated in solitary DLGGs.
11 Second, it also means that simultaneous resection of multiple gliomas located within different lobes but in the same hemisphere (including in the left hemisphere in right-handed patients) can be achieved with no addition risk. Finally, our results demonstrate that incidental multicentric DLGGs can be resected with no consequences on the quality of life as shown in the patient in Case 1, in agreement with previous reports in unicentric DLGGs.
10,29
Conclusions
Despite the small number of patients in this retrospective study, we demonstrate that multicentric DLGGs can be managed similarly to unicentric DLGGs. They can be extensively and safely removed without inducing permanent functional deficits thanks to the use of awake intraoperative brain mapping. Therefore, we suggest considering early surgery as the first therapeutic option in multicentric DLGGs, with reoperation(s) in cases of glioma relapse.
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